DK3035991T3 - Lægemiddelleveringsindretninger med flere enheder - Google Patents

Lægemiddelleveringsindretninger med flere enheder Download PDF

Info

Publication number
DK3035991T3
DK3035991T3 DK14756224.3T DK14756224T DK3035991T3 DK 3035991 T3 DK3035991 T3 DK 3035991T3 DK 14756224 T DK14756224 T DK 14756224T DK 3035991 T3 DK3035991 T3 DK 3035991T3
Authority
DK
Denmark
Prior art keywords
delivery devices
several units
pharmaceutical delivery
pharmaceutical
units
Prior art date
Application number
DK14756224.3T
Other languages
English (en)
Inventor
Karen Daniel
Matthew Sansone
Heejin Lee
Original Assignee
Taris Biomedical Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taris Biomedical Llc filed Critical Taris Biomedical Llc
Application granted granted Critical
Publication of DK3035991T3 publication Critical patent/DK3035991T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/048—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/007—Injectors for solid bodies, e.g. suppositories
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/10—Trunk
    • A61M2210/1078—Urinary tract
    • A61M2210/1085—Bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK14756224.3T 2013-08-19 2014-08-19 Lægemiddelleveringsindretninger med flere enheder DK3035991T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361867245P 2013-08-19 2013-08-19
US201361877610P 2013-09-13 2013-09-13
PCT/US2014/051672 WO2015026813A1 (en) 2013-08-19 2014-08-19 Multi-unit drug delivery devices and methods

Publications (1)

Publication Number Publication Date
DK3035991T3 true DK3035991T3 (da) 2020-09-21

Family

ID=51422208

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14756224.3T DK3035991T3 (da) 2013-08-19 2014-08-19 Lægemiddelleveringsindretninger med flere enheder

Country Status (23)

Country Link
US (3) US10729823B2 (da)
EP (3) EP3035991B1 (da)
JP (4) JP6486359B2 (da)
KR (3) KR102385603B1 (da)
CN (3) CN113413393A (da)
AU (3) AU2014309012B2 (da)
BR (1) BR112016002646B1 (da)
CA (2) CA2919215C (da)
CY (1) CY1123474T1 (da)
DK (1) DK3035991T3 (da)
ES (2) ES2956840T3 (da)
HR (1) HRP20201421T1 (da)
HU (1) HUE051336T2 (da)
IL (3) IL299897B2 (da)
LT (1) LT3035991T (da)
MX (2) MX2016001621A (da)
PL (1) PL3035991T3 (da)
PT (1) PT3035991T (da)
RS (1) RS60847B1 (da)
RU (1) RU2687596C2 (da)
SG (2) SG11201600856RA (da)
SI (1) SI3035991T1 (da)
WO (1) WO2015026813A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015004110A2 (pt) 2012-08-31 2017-07-04 Taris Biomedical Llc sistemas e métodos de distribuição de drogas para tratamento de próstata
PL2890384T3 (pl) 2012-08-31 2022-02-14 Taris Biomedical Llc Układy podawania leku i sposoby leczenia raka pęcherza obejmujące oksaliplatynę
EP2964310A1 (en) 2013-03-05 2016-01-13 TARIS Biomedical LLC Drug delivery devices and methods for controlled drug release through device orifice
KR102339132B1 (ko) 2013-03-15 2021-12-13 타리스 바이오메디컬 엘엘씨 약물 전달 장치 및 약물 전달 방법
RS63675B1 (sr) * 2014-03-06 2022-11-30 Taris Biomedical Llc Sistemi za isporuku leka i metode za lečenje raka bešike gemcitabinom
AU2015259361B2 (en) 2014-05-12 2020-11-05 Taris Biomedical Llc Drug delivery devices and methods
ES2728504T3 (es) 2014-06-26 2019-10-25 Taris Biomedical Llc Dispositivos de administración de fármacos por vía intravesical y métodos que comprenden sistemas matriciales polímero-fármaco elásticos
WO2016160934A1 (en) 2015-03-30 2016-10-06 Taris Biomedical Llc Devices and methods for local delivery of drug to upper urinary tract
EP3285850A1 (en) 2015-04-23 2018-02-28 TARIS Biomedical LLC Drug delivery devices with drug-permeable component and methods
WO2016176444A1 (en) * 2015-04-29 2016-11-03 Northwestern University 3d printing of biomedical implants
CN105056376A (zh) * 2015-08-21 2015-11-18 崔尚品 一种治疗宫颈炎和宫颈hpv感染的医疗器械
WO2017151983A1 (en) * 2016-03-02 2017-09-08 Taris Biomedical Llc Osmotic drug delivery devices and methods of making osmotic drug delivery devices
PL3452053T3 (pl) 2016-05-06 2023-05-08 Taris Biomedical Llc Sposób leczenia urotelialnego nowotworu złośliwego dolnych dróg
HUE054587T2 (hu) * 2017-02-01 2021-09-28 Taris Biomedical Llc In vivo gyógyszerbejuttató eszközök
WO2019023388A1 (en) 2017-07-25 2019-01-31 Taris Biomedical Llc METHODS OF TREATING TUMOR METASTASIS
WO2019094517A1 (en) 2017-11-08 2019-05-16 Taris Biomedical Llc Methods of treatment and maintenance therapy for bladder cancer using gemcitabine
WO2020028554A1 (en) 2018-08-01 2020-02-06 Taris Biomedical Llc Methods of treating overactive bladder using trospium
WO2023122058A1 (en) 2021-12-21 2023-06-29 Taris Biomedical Llc Urinary placement catheter for intravesical devices

Family Cites Families (143)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3089815A (en) 1951-10-11 1963-05-14 Lieb Hans Injectable pharmaceutical preparation, and a method of making same
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3948254A (en) * 1971-11-08 1976-04-06 Alza Corporation Novel drug delivery device
US4016251A (en) 1972-08-17 1977-04-05 Alza Corporation Vaginal drug dispensing device
US3888975A (en) 1972-12-27 1975-06-10 Alza Corp Erodible intrauterine device
US3901232A (en) 1973-10-26 1975-08-26 Alza Corp Integrated device for administering beneficial drug at programmed rate
US3935860A (en) 1974-08-21 1976-02-03 Alza Corporation Intrauterine device with restrictor for maintaining device in uterine cavity
US4111203A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system with means for improving delivery kinetics of system
US4210139A (en) * 1979-01-17 1980-07-01 Alza Corporation Osmotic device with compartment for governing concentration of agent dispensed from device
US4235236A (en) 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
US4392848A (en) 1979-06-25 1983-07-12 The Procter & Gamble Company Catheterization
US4309996A (en) 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
US4326522A (en) 1980-06-09 1982-04-27 Pitman-Moore, Inc. Mesh-covered bolus
GB2079158B (en) 1980-06-09 1985-01-09 Ahi Operations Ltd Intra-vaginal devices
US4475916A (en) 1982-03-18 1984-10-09 Merck & Co., Inc. Osmotic drug delivery system
US4629449A (en) 1982-07-29 1986-12-16 Alza Corporation Vaginal dispenser for dispensing beneficial hormone
US5366738A (en) 1982-07-29 1994-11-22 Merck & Co., Inc. Controlled release drug dispersion delivery device
US4681583A (en) 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4578075A (en) 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US4655219A (en) 1983-07-22 1987-04-07 American Hospital Supply Corporation Multicomponent flexible grasping device
DE3332156A1 (de) 1983-09-06 1985-03-21 Peter 6000 Frankfurt Prezelj Nasenspange
GB8328916D0 (en) 1983-10-28 1983-11-30 Castex Prod Pharmaceutical pellet
GB8403138D0 (en) 1984-02-07 1984-03-14 Graham N B Sustained release of active ingredient
NZ207341A (en) 1984-03-01 1988-02-29 Harvey Alex Ind Ltd Device containing chemical impregnants for insertion into a body cavity of an animal
US4968507A (en) 1984-06-20 1990-11-06 Merck & Co., Inc. Controlled porosity osmotic pump
CH667209A5 (de) 1985-07-02 1988-09-30 Sulzer Ag Medizinische depotsonde.
US5008112A (en) * 1985-12-16 1991-04-16 International Minerals & Chem. Corporation Device for the extended delivery of diffusible agents
US4871542A (en) 1987-04-30 1989-10-03 Ferring Service Center, N.V. Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract
US5340590A (en) * 1987-06-25 1994-08-23 Alza Corporation Delivery system with bilayer osmotic engine
US5057318A (en) * 1988-12-13 1991-10-15 Alza Corporation Delivery system for beneficial agent over a broad range of rates
US5545208A (en) 1990-02-28 1996-08-13 Medtronic, Inc. Intralumenal drug eluting prosthesis
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
WO1993006792A1 (en) 1991-10-04 1993-04-15 Scimed Life Systems, Inc. Biodegradable drug delivery vascular stent
AU2867492A (en) 1991-10-10 1993-05-03 Alza Corporation Osmotic drug delivery devices with hydrophobic wall materials
US5441550A (en) 1992-03-26 1995-08-15 The University Of Tennessee Research Corporation Post-treatment of laminated nonwoven cellulosic fiber webs
US5499997A (en) 1992-04-10 1996-03-19 Sharpe Endosurgical Corporation Endoscopic tenaculum surgical instrument
DE69329407T2 (de) 1992-06-02 2001-05-03 Bard Inc C R Verfahren und Implantatvorrichtung für Langzeitwirkstoffabgabe
US5523092A (en) 1993-04-14 1996-06-04 Emory University Device for local drug delivery and methods for using the same
US5516522A (en) 1994-03-14 1996-05-14 Board Of Supervisors Of Louisiana State University Biodegradable porous device for long-term drug delivery with constant rate release and method of making the same
IL116433A (en) 1994-12-19 2002-02-10 Galen Chemicals Ltd INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17β-OESTRADIOL PRECURSORS
GB9522403D0 (en) 1995-11-01 1996-01-03 Hoechst Roussel Ltd Intravaginal drug delivery device
ATE284202T1 (de) 1996-02-02 2004-12-15 Alza Corp Implantierbares system mit verzögerter wirkstofffreisetzung
US6171298B1 (en) 1996-05-03 2001-01-09 Situs Corporation Intravesical infuser
GB9610862D0 (en) 1996-05-23 1996-07-31 Evans Brian K Pharmaceutical products
US20070161967A1 (en) * 1996-06-04 2007-07-12 Vance Products Inc., Dba Cook Urological Inc. Implantable medical device with pharmacologically active ingredient
US5869081A (en) 1996-06-28 1999-02-09 The Population Council Progesterone vaginal ring for treatment of infertility
US5797898A (en) 1996-07-02 1998-08-25 Massachusetts Institute Of Technology Microchip drug delivery devices
US5972372A (en) 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
US5868719A (en) 1997-01-15 1999-02-09 Boston Scientific Corporation Drug delivery balloon catheter device
US5830230A (en) 1997-03-07 1998-11-03 Micro Therapeutics, Inc. Method of intracranial vascular embolotherapy using self anchoring coils
AU6876498A (en) 1997-04-03 1998-10-22 Point Biomedical Corporation Intravesical drug delivery system
IL123813A0 (en) 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
DK0981327T3 (da) 1997-05-07 2003-03-10 Galen Chemicals Ltd Intravaginale lægemiddeltilførselsanordninger til indgivelse af testosteron og testosteronprecursorer
JP4202431B2 (ja) 1997-05-28 2008-12-24 インターエージー 豚の腟内装置
US6197327B1 (en) 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
US6039968A (en) 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
US6267761B1 (en) 1997-09-09 2001-07-31 Sherwood Services Ag Apparatus and method for sealing and cutting tissue
DE69838223T2 (de) 1997-10-10 2008-05-08 Bioniche Life Science, Inc., Belleville Anordnung zur medikamentenzuführung
US6749617B1 (en) 1997-11-04 2004-06-15 Scimed Life Systems, Inc. Catheter and implants for the delivery of therapeutic agents to tissues
ATE248002T1 (de) * 1997-12-31 2003-09-15 Alza Corp System zur überwachung einer osmotischen wirkstoffabgabevorrichtung
US6183461B1 (en) 1998-03-11 2001-02-06 Situs Corporation Method for delivering a medication
US6482837B1 (en) 1998-04-24 2002-11-19 University Of Rochester Antimuscarinic compounds and methods for treatment of bladder diseases
US6159143A (en) 1998-06-17 2000-12-12 Scimed Life Systems, Inc. Method and device for delivery of therapeutic agents in conjunction with isotope seed placement
US6464999B1 (en) 1998-06-17 2002-10-15 Galt Incorporated Bioadhesive medical devices
US6168801B1 (en) 1998-09-09 2001-01-02 Cardiac Pacemakers, Inc. Controlled release drug delivery
AU1853400A (en) 1999-01-06 2000-07-24 Richard Henry Topical anesthesia of the urinary bladder
US6293923B1 (en) 1999-03-15 2001-09-25 Innoventions, Inc. Intravesicular balloon
US6083933A (en) 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
US6139535A (en) 1999-05-27 2000-10-31 Situs Corporation Method and apparatus for placement and activation of a medical device within a body cavity
EP2308522A3 (en) 1999-11-17 2012-02-29 Boston Scientific Limited Microfabricated devices for the delivery of molecules into a carrier fluid
US6808522B2 (en) 1999-12-10 2004-10-26 Massachusetts Institute Of Technology Microchip devices for delivery of molecules and methods of fabrication thereof
US20050238733A1 (en) 2000-01-05 2005-10-27 Richard Henry Topical anesthesia of the urinary bladder
US6753011B2 (en) 2000-01-14 2004-06-22 Osmotica Corp Combined diffusion/osmotic pumping drug delivery system
US6379382B1 (en) 2000-03-13 2002-04-30 Jun Yang Stent having cover with drug delivery capability
US6682473B1 (en) 2000-04-14 2004-01-27 Solace Therapeutics, Inc. Devices and methods for attenuation of pressure waves in the body
US6988983B2 (en) 2000-04-14 2006-01-24 Solace Therapeutics, Inc. Implantable self-inflating attenuation device
US7232421B1 (en) 2000-05-12 2007-06-19 C. R. Bard, Inc. Agent delivery systems
WO2001091902A2 (en) 2000-05-30 2001-12-06 Massachusetts Institute Of Technology Methods and devices for sealing microchip reservoir devices
US6398718B1 (en) 2000-06-15 2002-06-04 Innoventions, Inc. Intravesicular device
GB0015617D0 (en) 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
WO2002005800A2 (en) 2000-07-17 2002-01-24 Guilford Pharmaceuticals, Inc. Compositions for sustained release of analgesic agents, and methods of making and using the same
WO2002015832A1 (en) 2000-08-24 2002-02-28 Cornell Research Foundation, Inc. Non-hormonal vaginal contraceptive
US6752829B2 (en) 2001-01-30 2004-06-22 Scimed Life Systems, Inc. Stent with channel(s) for containing and delivering a biologically active material and method for manufacturing the same
DE10104369A1 (de) * 2001-02-01 2002-08-08 Boehringer Ingelheim Pharma Verwendung von 2-Amino-(4-hydroxy-2-methansulfonamidophenyl)ethanol zur Behandlung der Harninkontinenz
CN1536986B (zh) 2001-03-27 2012-07-04 沃纳奇尔科特(爱尔兰)有限公司 用于抗微生物剂给药的阴道内药物递送装置
US6632217B2 (en) 2001-04-19 2003-10-14 Microsolutions, Inc. Implantable osmotic pump
WO2002096389A1 (en) 2001-05-30 2002-12-05 Microchips, Inc. Conformal coated microchip reservoir devices
WO2002099457A1 (en) 2001-05-31 2002-12-12 Massachusetts Inst Technology Microchip devices with improved reservoir opening
US7438701B2 (en) 2001-07-26 2008-10-21 Durect Corporation Local concentration management system
US20030118649A1 (en) 2001-10-04 2003-06-26 Jinming Gao Drug delivery devices and methods
US7722894B2 (en) 2001-10-22 2010-05-25 Massachusetts Institute Of Technology Biodegradable polymer
US7005138B2 (en) 2001-12-21 2006-02-28 Duramed Pharmaceuticals, Inc. Method of systematically delivering SSRIs
US7473273B2 (en) 2002-01-22 2009-01-06 Medtronic Vascular, Inc. Stent assembly with therapeutic agent exterior banding
US8685427B2 (en) 2002-07-31 2014-04-01 Boston Scientific Scimed, Inc. Controlled drug delivery
GB2385273B (en) 2002-02-13 2004-05-26 Deborah Huang Drug delivery device
US6899890B2 (en) 2002-03-20 2005-05-31 Kv Pharmaceutical Company Bioadhesive drug delivery system
DE10247689A1 (de) 2002-10-12 2004-04-22 Martin Rahe Implantat in der Harnblase
US7504387B2 (en) 2002-10-16 2009-03-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
JP2006506385A (ja) 2002-10-22 2006-02-23 ザ バイオメリックス コーポレーション 治療剤を小嚢内デリバリーするための方法およびシステム
EP1587450A2 (en) 2002-12-16 2005-10-26 The Regents Of The University Of Michigan Assembly and planar structure for use therein which is expandable into a 3-d structure such as a stent and device for making the planar structure
EP1581287A1 (en) 2002-12-23 2005-10-05 Medtronic, Inc. Multiple infusion section catheters, systems, and methods
AR043809A1 (es) 2003-03-31 2005-08-17 Alza Corp Bomba osmotica con medio para disipar la presion interna
US20050228482A1 (en) 2003-09-26 2005-10-13 William Herzog Stent covered by a layer having a layer opening
DE10359828A1 (de) * 2003-12-12 2005-07-28 Zoser B. Dr.Rer.Nat. Salama CHP-Gemcitabin- Kombinationsmittel und ihre Verwendung als Antitumorwirkstoffe, insbesondere Antimetastasierungswirkstoffe
EP1708722B1 (en) 2004-01-28 2014-05-21 The Regents of The University of California Novel interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis
ATE534426T1 (de) 2004-02-10 2011-12-15 Synecor Llc Intravaskuläres abgabesystem für therapeutische mittel
US7647112B2 (en) 2004-02-11 2010-01-12 Ethicon, Inc. System and method for selectively stimulating different body parts
WO2005115245A1 (en) 2004-05-28 2005-12-08 Dynaventions Inc. Intravesicular device
EP1861161A4 (en) 2005-01-24 2012-05-16 Neurosystec Corp APPARATUS AND METHOD FOR DISPENSING THERAPEUTIC AND / OR OTHER AGENTS IN THE INTERNAL EAR AND OTHER FABRICS
US20060259118A1 (en) 2005-04-20 2006-11-16 Dharmendra Pal Delivery system and devices for the rapid insertion of self-expanding devices
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
DK1933810T3 (da) 2005-08-11 2013-01-28 Childrens Medical Center Intravesikal lægemiddelafgivelsesindretning og fremgangsmåde
US20100003297A1 (en) 2005-08-11 2010-01-07 Massachusetts Institute Of Technology Implantable Drug Delivery Device and Methods of Treating Male Genitourinary and Surrounding Tissues
US20070172507A1 (en) 2006-01-26 2007-07-26 Paul Zupkas Transluminal drug delivery methods and devices
US20070172508A1 (en) 2006-01-26 2007-07-26 Paul Zupkas Transluminal drug delivery methods and devices
BRPI0709344A2 (pt) 2006-03-20 2011-07-12 Duramed Pharmaceuticals Inc anel intravaginal comprimido flexìvel, seu uso e processo de preparação, método de fornecer um agente ativo, kit terapêutico e produto
KR20110038144A (ko) 2006-03-31 2011-04-13 큐엘티 플러그 딜리버리, 인코포레이티드 비루관계에 대한 약물 전달 방법, 구조, 및 조성물
US7824383B2 (en) 2006-06-16 2010-11-02 Family Health International Vaginal drug delivery system and method
EP2096983A2 (en) 2006-09-28 2009-09-09 Medvision Inc. Examination device
US8093261B2 (en) 2006-10-24 2012-01-10 The Johns Hopkins University Rapid release mini-tablets provide analgesia in laboratory animals
EP2136855A2 (en) 2007-03-20 2009-12-30 Boston Scientific Scimed, Inc. Urological medical devices for release of prostatically beneficial therapeutic agents
CN101827581A (zh) 2007-06-26 2010-09-08 沃纳奇尔科特有限责任公司 用于递送大分子和水溶性药物的阴道内药物递送装置
WO2009029958A2 (en) 2007-08-30 2009-03-05 Sunstorm Research Corporation Implantable delivery device
CN201179205Y (zh) * 2007-11-28 2009-01-14 北京星昊医药股份有限公司 双氯芬酸钠双释胶囊片
JP5560200B2 (ja) 2007-12-11 2014-07-23 マサチューセッツ インスチテュート オブ テクノロジー 膀胱および他の身体の小嚢又は管腔を治療するための埋め込み型薬物供給デバイス
RU2011101459A (ru) 2008-06-16 2012-07-27 Аппиан Лабс, Ллк (Us) Композиция и способ получения систем высвобождения для постоянного (нулевого порядка) высвобождения активных средств
WO2010105093A2 (en) * 2009-03-12 2010-09-16 Delpor, Inc. Implantable device for long-term delivery of drugs
AU2010265866B2 (en) * 2009-06-26 2012-07-12 Taris Biomedical Llc Solid drug tablets for implantable drug delivery devices
US9017312B2 (en) * 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
US8167836B2 (en) * 2009-12-08 2012-05-01 Taris Biomedical, Inc. Tissue expander configured for drug delivery
DK2512581T3 (da) 2009-12-17 2021-03-29 Taris Biomedical Llc Implanterbar indretning med intravesikal tolerance
US20110218488A1 (en) * 2010-03-05 2011-09-08 Taris Biomedical, Inc. Systems and Methods for Implanting Devices in the Bladder and Other Genitourinary Sites
JP5945544B2 (ja) * 2010-10-06 2016-07-05 タリス バイオメディカル エルエルシー 時間選択的に生体吸収可能または崩壊可能な薬剤送達システムおよび方法
WO2012048104A1 (en) * 2010-10-06 2012-04-12 Taris Biomedical, Inc. Implantable drug delivery device with bladden retention feature
AU2012205654B2 (en) * 2011-01-10 2016-09-08 Allergan, Inc. Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding
US9107816B2 (en) 2011-02-04 2015-08-18 Taris Biomedical Llc Implantable device for controlled dissolution and diffusion of low solubility drug
TWI615155B (zh) 2011-11-01 2018-02-21 拜耳股份有限公司 滲透活性的陰道遞送系統
BR112015004110A2 (pt) 2012-08-31 2017-07-04 Taris Biomedical Llc sistemas e métodos de distribuição de drogas para tratamento de próstata
JP6178861B2 (ja) * 2012-11-02 2017-08-09 ファイザー・インク ブルトン型チロシンキナーゼ阻害剤
EP2964310A1 (en) 2013-03-05 2016-01-13 TARIS Biomedical LLC Drug delivery devices and methods for controlled drug release through device orifice
KR102339132B1 (ko) 2013-03-15 2021-12-13 타리스 바이오메디컬 엘엘씨 약물 전달 장치 및 약물 전달 방법
NZ711546A (en) 2013-03-15 2017-12-22 Taris Biomedical Llc Drug delivery devices with drug-permeable component and methods
RS63675B1 (sr) 2014-03-06 2022-11-30 Taris Biomedical Llc Sistemi za isporuku leka i metode za lečenje raka bešike gemcitabinom

Also Published As

Publication number Publication date
IL299897A (en) 2023-03-01
KR20160045777A (ko) 2016-04-27
JP2016532505A (ja) 2016-10-20
EP3736015A1 (en) 2020-11-11
RU2687596C2 (ru) 2019-05-15
SI3035991T1 (sl) 2021-01-29
CN105530987A (zh) 2016-04-27
AU2014309012A1 (en) 2016-02-11
BR112016002646B1 (pt) 2022-01-25
KR102488491B1 (ko) 2023-01-12
WO2015026813A1 (en) 2015-02-26
AU2019203394B2 (en) 2021-09-09
RS60847B1 (sr) 2020-10-30
CA2919215A1 (en) 2015-02-26
KR102385603B1 (ko) 2022-04-11
RU2016108968A3 (da) 2018-08-28
CN113413393A (zh) 2021-09-21
IL282042A (en) 2021-05-31
ES2817838T3 (es) 2021-04-08
IL282042B1 (en) 2023-03-01
CN105530987B (zh) 2021-07-06
PL3035991T3 (pl) 2021-01-25
CN113413537A (zh) 2021-09-21
RU2016108968A (ru) 2017-09-26
EP3035991B1 (en) 2020-07-08
US20200353131A1 (en) 2020-11-12
KR20220049048A (ko) 2022-04-20
IL243714B (en) 2021-04-29
KR102503010B1 (ko) 2023-02-24
EP3035991A1 (en) 2016-06-29
CA2919215C (en) 2022-11-29
AU2014309012B2 (en) 2019-03-14
NZ716207A (en) 2020-12-18
MX2016001621A (es) 2016-06-02
HRP20201421T1 (hr) 2020-12-11
US20160199544A1 (en) 2016-07-14
IL282042B2 (en) 2023-07-01
IL299897B1 (en) 2023-10-01
SG10202004675QA (en) 2020-06-29
US10729823B2 (en) 2020-08-04
LT3035991T (lt) 2020-11-10
HUE051336T2 (hu) 2021-03-01
JP6743213B2 (ja) 2020-08-19
SG11201600856RA (en) 2016-03-30
AU2019203394A1 (en) 2019-06-06
JP2020182875A (ja) 2020-11-12
ES2956840T3 (es) 2023-12-29
IL243714A0 (en) 2016-04-21
IL299897B2 (en) 2024-02-01
JP2022177236A (ja) 2022-11-30
BR112016002646A2 (pt) 2017-08-01
CY1123474T1 (el) 2022-03-24
KR20220049049A (ko) 2022-04-20
EP3736015B1 (en) 2023-06-28
AU2021282405A1 (en) 2021-12-23
JP2019103837A (ja) 2019-06-27
US20200360574A1 (en) 2020-11-19
PT3035991T (pt) 2020-10-06
MX2021012349A (es) 2021-10-22
EP3736015C0 (en) 2023-06-28
JP6486359B2 (ja) 2019-03-20
CA3173027A1 (en) 2015-02-26
RU2019112821A (ru) 2019-06-06
EP4234036A2 (en) 2023-08-30
EP4234036A3 (en) 2023-11-01

Similar Documents

Publication Publication Date Title
DK3035991T3 (da) Lægemiddelleveringsindretninger med flere enheder
DK3368108T3 (da) Medikamenttilførselsanordning
DK3062849T3 (da) Medikamentadministrationsanordning
HK1211517A1 (en) Drug delivery device
HK1211520A1 (en) Drug delivery device
BR112016009485A2 (pt) Inalador de medicamento
SG11201508647UA (en) Drug delivery device
EP2961469A4 (en) DEVICE FOR DELIVERY OF MEDICAMENT
HK1211519A1 (en) Drug delivery device
GB201313782D0 (en) Drug delivery device
DK3639872T3 (da) Lægemiddeladministrationsanordning
DK3038674T3 (da) Medikamentafgivelsesindretning
BR112015026025A2 (pt) dispositivo para administração de medicamento
SG11201600371XA (en) Drug delivery device
HK1219451A1 (zh) 藥物輸送裝置
DK3590499T3 (da) Inhalerbare lægemidler
HK1219682A1 (zh) 藥物輸送裝置
DE112014004954T8 (de) Abgabesystem
HK1219450A1 (zh) 藥物輸送裝置
HK1219685A1 (zh) 藥物輸送裝置
DK3071265T3 (da) Fjederassisteret lægemiddeladministrationsanordning
DE112014004938T8 (de) Abgabesystem
HK1219681A1 (zh) 藥物輸送裝置
DK3079667T3 (da) Farmaceutiske doseringsformer
DK3003401T3 (da) Farmaceutisk præparat